CFTR and prostate carcinoma: In contrast, CFTR has also been reported to function as a tumor suppressor 33, and downregulation or mutation of CFTR activates proliferation, invasion, migration, and the epithelial–mesenchymal transition in breast cancer and prostate cancer 34, 35, 36.